{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:27:38Z","timestamp":1787894858863,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.athoracsur.2021.08.038","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T11:24:18Z","timestamp":1632396258000},"page":"1794-1802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epstein-Barr Virus Predicts Malignancy After Pediatric Heart Transplant, Induction Therapy and Tacrolimus Don\u2019t"],"prefix":"10.1016","volume":"114","author":[{"given":"Katherine","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Canner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi Braud","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Charles D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ravekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Mettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Gottlieb","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2021.08.038_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2010.10.004","article-title":"Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients","volume":"30","author":"Dayton","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1651-2227.2011.02377.x","article-title":"First two decades of paediatric heart transplantation in Sweden - outcome of listing and post-transplant results","volume":"100","author":"Gilljam","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-3046.2006.00609.x","article-title":"Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort","volume":"11","author":"Katz","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report\u20142019; focus theme: donor and recipient size match","volume":"38","author":"Rossano","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib6","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/j.1600-6143.2012.04197.x","article-title":"A\u00a016-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients","volume":"12","author":"Chinnock","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-3046.2005.00401.x","article-title":"Post-transplant lymphoproliferative disorder following pediatric heart transplantation","volume":"10","author":"Mendoza","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.healun.2010.01.013","article-title":"Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients","volume":"29","author":"Manlhiot","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13521","article-title":"Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: a multicenter analysis","volume":"33","author":"West","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MOT.0000000000000227","article-title":"Post-transplant lymphoproliferative disease and other malignancies after pediatric cardiac transplantation: an evolving landscape","volume":"20","author":"Haynes","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.healun.2017.05.010","article-title":"Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: a multi-institutional study","volume":"37","author":"Castleberry","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.healun.2018.07.018","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-first pediatric heart transplantation report-2018; focus theme: multiorgan transplantation","volume":"37","author":"Rossano","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.healun.2010.09.005","article-title":"Infection and malignancy after pediatric heart transplantation: the role of induction therapy","volume":"30","author":"Gajarski","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib14","first-page":"94","article-title":"The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients","volume":"70","author":"Younes","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1053-2498(01)00407-7","article-title":"Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients","volume":"21","author":"Malouf","year":"2002","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib16","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.healun.2007.09.027","article-title":"Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients","volume":"27","author":"Schubert","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib18","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/CMR.00006-09","article-title":"Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder","volume":"23","author":"Gulley","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3476(97)70173-2","article-title":"Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients","volume":"131","author":"Boyle","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.healun.2006.06.010","article-title":"Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation","volume":"25","author":"O\u2019Neill","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib22","doi-asserted-by":"crossref","first-page":"814973","DOI":"10.1155\/2013\/814973","article-title":"Posttransplant lymphoproliferative disease after pediatric solid organ transplantation","volume":"2013","author":"Mynarek","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.athoracsur.2021.08.038_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.bjc.6602162","article-title":"Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer","volume":"91","author":"Chan","year":"2004","journal-title":"Br J Cancer"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497521015988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497521015988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:13:12Z","timestamp":1757736792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497521015988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0003497521015988"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2021.08.038","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr Virus Predicts Malignancy After Pediatric Heart Transplant, Induction Therapy and Tacrolimus Don\u2019t","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2021.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The Society of Thoracic Surgeons","name":"copyright","label":"Copyright"}]}}